Sign in

CIK 0001579428

  • Large accelerated filer

Axsome Therapeutics, Inc.

Sign in to watch
Ticker
AXSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
454241907
Phone
+1 212-332-3241
Business address
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,086,500
in 1 filing, $2.1M under 10b5-1 plans

Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Jacobson Mark L. −$2.1M Chief Operating Officer sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2019-06-11 Pizzie Nick Chief Financial Officer Purchase +1,920 $20.80 $40K 1,920
2019-05-23 Saad Mark E Director Purchase +3,500 $22.33 $78K 7,002
2019-05-13 Coleman Mark Director Purchase +4,650 $21.44 $100K 652,648
2019-03-19 Pizzie Nick Chief Financial Officer Purchase +60 $12.69 $761 60
2019-03-19 Pizzie Nick Chief Financial Officer Purchase +5,340 $12.58 $67K 36,340
2019-03-19 Coleman Mark Director Purchase +5,100 $12.18 $62K 5,100
2018-06-19 Pizzie Nick Chief Financial Officer Purchase +400 $3.05 $1K 400
2018-06-19 Pizzie Nick Chief Financial Officer Purchase +30,600 $3.10 $95K 31,000
2015-12-23 Kaye Randall Chief Medical Officer Purchase +1,000 $9.03 $9K 6,022

Page 2 of 2 · 29 trades